EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Roles of STAT3 in the pathogenesis and treatment of glioblastoma

Weijia Fu, Xue Hou, Lihua Dong, Wei Hou

Frontiers in Cell and Developmental Biology · 27.02.2023 · 11

DOI: 10.3389/fcell.2023.1098482 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 27.02.2023. Verfasst von Weijia Fu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology & Therapy, The First Hospital of Jilin University, Changchun, China. Die Arbeit wurde bisher 90-mal zitiert (Crossref) und nennt 146 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jilin Scientific and Technological Development Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM) is the most malignant of astrocytomas mainly involving the cerebral hemispheres and the cerebral cortex. It is one of the fatal and refractory solid tumors, with a 5-year survival rate of merely 5% among the adults. IL6/JAK/STAT3 is an important signaling pathway involved in the pathogenesis and progression of GBM. The expression of STAT3 in GBM tissues is substantially higher than that of normal brain cells. The abnormal activation of STAT3 renders the tumor microenvironment of GBM immunosuppression. Besides, blocking the STAT3 pathway can effectively inhibit the growth and metastasis of GBM. On this basis, inhibition of STAT3 may be a new therapeutic approach for GBM, and the combination of STAT3 targeted therapy and conventional therapies may improve the current status of GBM treatment. This review summarized the roles of STAT3 in the pathogenesis of GBM and the feasibility of STAT3 for GBM target therapy.

Schlagwörter

Stichwörter der Autor:innen

combination therapyglioblastomaradiotherapystat3targeted therapy

Autor:innen und Institutionen

  • Department of Radiation Oncology & Therapy, The First Hospital of Jilin University, Changchun, China.
  • Jilin Provincial Key Laboratory of Radiation Oncology & Therapy, The First Hospital of Jilin University, Changchun, China.
  • NHC Key Laboratory of Radiobiology, School of Public Health, Jilin University, Changchun, China.

Förderung

  • Jilin Scientific and Technological Development Program

Zitieren

APA

Fu, W., Hou, X., Dong, L., & Hou, W. (2023). Roles of STAT3 in the pathogenesis and treatment of glioblastoma. Frontiers in Cell and Developmental Biology, 11. https://doi.org/10.3389/fcell.2023.1098482

Vancouver

Fu W, Hou X, Dong L, Hou W. Roles of STAT3 in the pathogenesis and treatment of glioblastoma. Frontiers in Cell and Developmental Biology. 2023;11. doi:10.3389/fcell.2023.1098482

BibTeX
@article{Fu2023,
  author = {Fu, Weijia and Hou, Xue and Dong, Lihua and Hou, Wei},
  title = {Roles of STAT3 in the pathogenesis and treatment of glioblastoma},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2023},
  volume = {11},
  doi = {10.3389/fcell.2023.1098482}
}
Kostenlos starten →